American Express’ 5% Workforce Cut Puts Cost Discipline in the Spotlight
American Express will cut 5% of its workforce and record a $336 million restructuring charge after a mixed third quarter.
Elicio’s Pancreatic Cancer Trial Misses Endpoint Despite Positive Subgroup Signal
Elicio’s Phase 2 pancreatic cancer trial missed its primary endpoint, while a subgroup signal raises…
IDEAYA’s IDE849 Data Put Dose, Safety and Pipeline Economics in Focus
IDE849’s Grade 3+ adverse-event rates rose from 5% to 22.2% across doses, sharpening questions about…
Rapport Director Buys Nearly $1 Million as Analyst Raises Price Target to $82
Insider buying and a higher $82 price target put Rapport Therapeutics’ clinical pipeline under the m…
Visa’s Reported Fireblocks Talks Point to a Bigger Crypto Infrastructure Bet
Visa’s reported talks to acquire Fireblocks for about $2.5 billion could signal a deeper push into i…
Biohaven Stock Jumps 25% After FDA Accepts Resubmitted Vyglxia Filing
BHVN jumped 25% after the FDA accepted Biohaven’s resubmitted Vyglxia filing, but acceptance is not …
AstraZeneca Launches Zegfrovy in U.S. After Accelerated FDA Approval
AstraZeneca’s U.S. launch of Zegfrovy opens a potential oncology revenue stream, but accelerated app…
Visa’s Reported Fireblocks Talks Show Payments Giant Pushing Deeper Into Crypto Infrastructure
Visa’s reported $2.5 billion Fireblocks talks could deepen its role in blockchain and stablecoin inf…
AbbVie’s INTREPID Data Strengthens the Case for Dermatology Pipeline Diversification
AbbVie’s Phase 3 INTREPID results show stronger hidradenitis suppurativa responses than the comparat…
Biohaven Stock Jumps as FDA Accepts Troriluzole Resubmission and Ono Deal Adds Validation
Biohaven’s $BHVN shares jumped 25% after FDA acceptance of its troriluzole resubmission, while an On…